Pacific Edge Ltd

AU:PEB Australia Diagnostics & Research
Market Cap
$104.45 Million
AU$168.68 Million AUD
Market Cap Rank
#18707 Global
#298 in Australia
Share Price
AU$0.17
Change (1 day)
+3.13%
52-Week Range
AU$0.07 - AU$0.22
All Time High
AU$1.54
About

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more

Pacific Edge Ltd (PEB) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.707x

Based on the latest financial reports, Pacific Edge Ltd (PEB) has a cash flow conversion efficiency ratio of -0.707x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-18.87 Million) by net assets (AU$26.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Pacific Edge Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Pacific Edge Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Pacific Edge Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pacific Edge Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Pacific Edge Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Pacific Edge Ltd from 2005 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 AU$26.09 Million AU$-24.74 Million -0.948x -119.32%
2024-03-31 AU$59.55 Million AU$-25.75 Million -0.432x -49.49%
2023-03-31 AU$88.41 Million AU$-25.57 Million -0.289x -92.16%
2022-03-31 AU$116.60 Million AU$-17.55 Million -0.151x +72.15%
2021-03-31 AU$25.11 Million AU$-13.57 Million -0.540x +49.05%
2020-03-31 AU$14.50 Million AU$-15.38 Million -1.061x +15.72%
2019-03-31 AU$13.91 Million AU$-17.51 Million -1.259x -15.71%
2018-03-31 AU$16.64 Million AU$-18.10 Million -1.088x -27.02%
2017-03-31 AU$20.83 Million AU$-17.84 Million -0.856x -50.57%
2016-03-31 AU$29.81 Million AU$-16.95 Million -0.569x +51.46%
2015-03-31 AU$10.70 Million AU$-12.54 Million -1.172x -167.91%
2014-03-31 AU$21.78 Million AU$-9.52 Million -0.437x +27.37%
2013-03-31 AU$11.15 Million AU$-6.71 Million -0.602x -195.27%
2012-03-31 AU$17.68 Million AU$-3.60 Million -0.204x +81.20%
2011-03-31 AU$2.69 Million AU$-2.92 Million -1.085x +50.51%
2010-03-31 AU$1.13 Million AU$-2.47 Million -2.192x +77.26%
2009-03-31 AU$257.17K AU$-2.48 Million -9.637x -1420.51%
2008-03-31 AU$2.43 Million AU$-1.54 Million -0.634x +87.79%
2007-03-31 AU$336.81K AU$-1.75 Million -5.193x -194.48%
2006-03-31 AU$974.17K AU$-1.72 Million -1.763x +3.23%
2005-03-31 AU$1.12 Million AU$-2.04 Million -1.822x --